DK609889A - Vandig doxorubicinoploesning - Google Patents

Vandig doxorubicinoploesning Download PDF

Info

Publication number
DK609889A
DK609889A DK609889A DK609889A DK609889A DK 609889 A DK609889 A DK 609889A DK 609889 A DK609889 A DK 609889A DK 609889 A DK609889 A DK 609889A DK 609889 A DK609889 A DK 609889A
Authority
DK
Denmark
Prior art keywords
doxorubicin solution
doxorubicin
physiologically acceptable
solution
aqueous doxorubicin
Prior art date
Application number
DK609889A
Other languages
Danish (da)
English (en)
Other versions
DK609889D0 (da
Inventor
Murray A Kaplan
Robert K Perrone
Joseph B Bogardus
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK609889D0 publication Critical patent/DK609889D0/da
Publication of DK609889A publication Critical patent/DK609889A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
  • Lubricants (AREA)
  • Steroid Compounds (AREA)
DK609889A 1988-12-05 1989-12-04 Vandig doxorubicinoploesning DK609889A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27962788A 1988-12-05 1988-12-05

Publications (2)

Publication Number Publication Date
DK609889D0 DK609889D0 (da) 1989-12-04
DK609889A true DK609889A (da) 1990-06-06

Family

ID=23069771

Family Applications (1)

Application Number Title Priority Date Filing Date
DK609889A DK609889A (da) 1988-12-05 1989-12-04 Vandig doxorubicinoploesning

Country Status (20)

Country Link
EP (1) EP0372888B1 (fr)
JP (1) JPH02200637A (fr)
KR (1) KR920001460B1 (fr)
AT (1) ATE78402T1 (fr)
AU (1) AU612916B2 (fr)
DD (1) DD295990A5 (fr)
DE (1) DE68902223T2 (fr)
DK (1) DK609889A (fr)
ES (1) ES2044148T3 (fr)
FI (1) FI895733A0 (fr)
GR (1) GR3005391T3 (fr)
HU (1) HU204704B (fr)
IE (1) IE893867L (fr)
IL (1) IL92541A0 (fr)
NO (1) NO894811L (fr)
NZ (1) NZ231602A (fr)
OA (1) OA09898A (fr)
PT (1) PT92483B (fr)
YU (1) YU226189A (fr)
ZA (1) ZA899248B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006085336A2 (fr) * 2005-02-11 2006-08-17 Dabur Pharma Limited Compositions pharmaceutiques stabilisees comprenant un glycoside d'anthracycline
JP7082943B2 (ja) * 2016-02-16 2022-06-09 一般社団法人ファルマバレープロジェクト支援機構 免疫抑制解除剤及びその利用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.

Also Published As

Publication number Publication date
YU226189A (en) 1991-02-28
DE68902223D1 (de) 1992-08-27
JPH02200637A (ja) 1990-08-08
NO894811L (no) 1990-06-06
DE68902223T2 (de) 1993-01-14
NO894811D0 (no) 1989-12-01
ATE78402T1 (de) 1992-08-15
ES2044148T3 (es) 1994-01-01
PT92483B (pt) 1995-08-09
KR900009081A (ko) 1990-07-02
GR3005391T3 (fr) 1993-05-24
EP0372888A1 (fr) 1990-06-13
EP0372888B1 (fr) 1992-07-22
AU4591589A (en) 1990-06-07
IE893867L (en) 1990-06-05
OA09898A (fr) 1994-09-15
PT92483A (pt) 1990-06-29
NZ231602A (en) 1991-12-23
ZA899248B (en) 1990-08-29
DK609889D0 (da) 1989-12-04
KR920001460B1 (ko) 1992-02-14
IL92541A0 (en) 1990-08-31
HU204704B (en) 1992-02-28
DD295990A5 (de) 1991-11-21
AU612916B2 (en) 1991-07-18
FI895733A0 (fi) 1989-11-30
HU896426D0 (en) 1990-02-28
HUT52961A (en) 1990-09-28

Similar Documents

Publication Publication Date Title
SE8402551L (sv) Cinnamoylmoranolin-derivat
NO863061D0 (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
FI854167A0 (fi) Mun- och tandvaordsmedel.
DK0490549T3 (da) Stabilisering af calcitonin-holdige farmaceutiske præparater
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
ES2033379T3 (es) Soluciones acuosas de clorhidrato de doxorubicina.
SE9102604L (sv) Farmaceutiska kompositioner innehaallande furanderivat
KR900009081A (ko) 독소루비신 수용액
DE69003061D1 (de) Protein enthaltende wässerige Lösungen.
ATE87210T1 (de) Doxorubicin-loesungen.
ES8705866A1 (es) Procedimiento de preparar sales fungicidas
DK214884A (da) Chlorphenoxyacetatderivat

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment